Company Profile

Brii Biosciences Ltd. (OTC: BRIBY)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -16.54
% Price Change (last 13 weeks): 4.19
% Price Change (last 26 weeks): -55.33
% Price Change (last 52 weeks): -68.38
% Price Change (year to date): -55.48
Management Effectiveness
Return on Equity (%): -5.49
Return on Assets (%): -5.26
Return on Invested Capital (%): -169.85
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -28335.33
Operating Profit Margin (%): -97245.71
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
Brii Biosciences Ltd.
Zhongguancun Dongsheng, Building 7 1 North Yongtaizhuang Road 3rd Floor
Haidian BE 100192

Phone: n/a
Fax: n/a
http://www.briibio.com
Per Share Data
Earnings (1year) ($): -0.17
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 3.01
Cash Flow ($): -0.15
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 2441.35
Price/Book (x): 0.48
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 22.11
Current Ratio (x): 22.11
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.10



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.